This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (64)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Genetic Disorders  • Alzheimer Disease  • Neurogenetics  • Alert me on articles by topic

Relation to Apolipoprotein E Allele Status

Denis A. Evans, MD; David A. Bennett, MD; Robert S. Wilson, PhD; Julia L. Bienias, ScD; Martha Clare Morris, ScD; Paul A. Scherr, ScD; Liesi E. Hebert, ScD; Neelum Aggarwal, MD; Laurel A. Beckett, PhD; Rajiv Joglekar, MD; Elizabeth Berry-Kravis, PhD; Julie Schneider, MD

Arch Neurol. 2003;60:185-189.

Context  Few studies compare Alzheimer disease (AD) incidence among black and white subjects.

Objective  To estimate incidence and the effect of the apolipoprotein E (APOE) 4 allele in these races.

Design  Population-based study of disease incidence using a random, stratified sample.

Setting  A geographically defined community of 3 adjacent neighborhoods in Chicago, Ill.

Participants  A total of 6158 persons (78.7% overall; 80.5% of the black subjects and 74.6% of the white subjects) participated; 4.1 years later, persons initially free of AD were sampled for clinical evaluation for disease incidence (overall 842 persons [74.8%] participated; 67.6% of the black subjects and 81.9% of the white subjects).

Interventions  None.

Main Outcome Measure  Incident, clinically diagnosed AD.

Results  The effect of the APOE 4 allele on the risk of AD differed strongly for black and white subjects. Among white subjects, the presence of the APOE 4 allele was associated with a 2.73-fold (95% confidence interval [CI], 1.40-5.32) increase in risk while among black subjects there was no increase in risk (odds ratio, 1.02; 95% confidence interval, 0.39-2.68). Black race was associated with a nonsignificantly increased risk of AD with an odds ratio of 1.84 (95% CI, 0.73-4.66) if APOE and its interaction with race are considered, and an odds ratio of 1.28 (95% CI, 0.54-2.98) if they are not. The incidence of AD was 1.45% (95% CI, 0.89%-2.01%) per year among persons 65 to 74 years old, 4.73% (95% CI, 3.83%-5.64%) among those 75 to 84 years old, and 9.11% (95% CI, 7.36%-10.9%) among those 85 years and older.

Conclusion  Apolipoprotein E 4 led to increased risk of AD among white subjects but not black subjects.

From the Rush Institute on Healthy Aging (Drs Evans, Bienias, Morris, and Hebert), the Rush Alzheimer's Disease Center (Drs Bennett, Wilson, Aggarwal, and Schneider), the Department of Pediatrics (Dr Berry-Kravis), and the Section of Geriatric Medicine, Department of Internal Medicine (Dr Joglekar), Rush-Presbyterian–St Luke's Medical Center, Chicago, Ill; Division of Adult and Community Health, Centers for Disease Control and Prevention, Atlanta, Ga (Dr Scherr); and the Department of Epidemiology and Preventive Medicine, University of California, Davis (Dr Beckett).

RELATED ARTICLE

Apolipoprotein E, Alzheimer Disease, and African Americans
Richard Mayeux
Arch Neurol. 2003;60(2):161-163.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Body mass index and cognitive decline in a biracial community population
Sturman et al.
Neurology 2008;70:360-367.
ABSTRACT | FULL TEXT  

Olfactory Identification and Incidence of Mild Cognitive Impairment in Older Age
Wilson et al.
Arch Gen Psychiatry 2007;64:802-808.
ABSTRACT | FULL TEXT  

How common are the "common" neurologic disorders?
Hirtz et al.
Neurology 2007;68:326-337.
ABSTRACT | FULL TEXT  

Long-term Effects of Cognitive Training on Everyday Functional Outcomes in Older Adults
Willis et al.
JAMA 2006;296:2805-2814.
ABSTRACT | FULL TEXT  

Associations of vegetable and fruit consumption with age-related cognitive change
Morris et al.
Neurology 2006;67:1370-1376.
ABSTRACT | FULL TEXT  

Dietary Copper and High Saturated and trans Fat Intakes Associated With Cognitive Decline.
Morris et al.
Arch Neurol 2006;63:1085-1088.
ABSTRACT | FULL TEXT  

Association of apolipoprotein e genotype and Alzheimer disease in african americans.
Murrell et al.
Arch Neurol 2006;63:431-434.
ABSTRACT | FULL TEXT  

Fish Consumption and Cognitive Decline With Age in a Large Community Study
Morris et al.
Arch Neurol 2005;62:1849-1853.
ABSTRACT | FULL TEXT  

Racial Differences in the Progression of Cognitive Decline in Alzheimer Disease
Barnes et al.
AJGP 2005;13:959-967.
ABSTRACT | FULL TEXT  

Racial Differences in Cognitive Decline in a Sample of Community-Dwelling Older Adults: The Mediating Role of Education and Literacy
Sachs-Ericsson and Blazer
AJGP 2005;13:968-975.
ABSTRACT | FULL TEXT  

Physical Activity, Cognitive Activity, and Cognitive Decline in a Biracial Community Population
Sturman et al.
Arch Neurol 2005;62:1750-1754.
ABSTRACT | FULL TEXT  

Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people
Bennett et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1194-1199.
ABSTRACT | FULL TEXT  

Racial Disparities in Disability: Recent Evidence From Self-Reported and Performance-Based Disability Measures in a Population-Based Study of Older Adults
Mendes de Leon et al.
J. Gerontol. B Psychol. Sci. Soc. Sci. 2005;60:S263-S271.
ABSTRACT | FULL TEXT  

Do Depressive Symptoms Predict Declines in Physical Performance in an Elderly, Biracial Population?
Everson-Rose et al.
Psychosom. Med. 2005;67:609-615.
ABSTRACT | FULL TEXT  

Apolipoprotein E and Progression of Chronic Kidney Disease
Hsu et al.
JAMA 2005;293:2892-2899.
ABSTRACT | FULL TEXT  

Black-White Differences in Depressive Symptoms Among Older Adults Over Time
Skarupski et al.
J. Gerontol. B Psychol. Sci. Soc. Sci. 2005;60:P136-P142.
ABSTRACT | FULL TEXT  

Dietary Folate and Vitamin B12 Intake and Cognitive Decline Among Community-Dwelling Older Persons
Morris et al.
Arch Neurol 2005;62:641-645.
ABSTRACT | FULL TEXT  

Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change
Morris et al.
Am. J. Clin. Nutr. 2005;81:508-514.
ABSTRACT | FULL TEXT  

APOE genotype and cognitive decline in a middle-aged cohort
Blair et al.
Neurology 2005;64:268-276.
ABSTRACT | FULL TEXT  

Social resources and cognitive decline in a population of older African Americans and whites
Barnes et al.
Neurology 2004;63:2322-2326.
ABSTRACT | FULL TEXT  

Methodology and Preliminary Results From the Neurocognitive Outcomes of Depression in the Elderly Study
Steffens et al.
J Geriatr Psychiatry Neurol 2004;17:202-211.
ABSTRACT  

The Effect of Menopause on Grip and Pinch Strength: Results from the Chicago, Illinois, Site of the Study of Women's Health Across the Nation
Kurina et al.
Am J Epidemiol 2004;160:484-491.
ABSTRACT | FULL TEXT  

Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline
Morris et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:1093-1099.
ABSTRACT | FULL TEXT  

Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex
Qiu et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:828-833.
ABSTRACT | FULL TEXT  

Dietary fat intake and 6-year cognitive change in an older biracial community population
Morris et al.
Neurology 2004;62:1573-1579.
ABSTRACT | FULL TEXT  

State-specific projections through 2025 of Alzheimer disease prevalence
Hebert et al.
Neurology 2004;62:1645-1645.
FULL TEXT  

Year 2000 Prevalence of Alzheimer Disease in the United States
Grant
Arch Neurol 2004;61:802-803.
FULL TEXT  

Depressive symptoms and cognitive decline in a community population of older persons
Wilson et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:126-129.
ABSTRACT | FULL TEXT  

The Role of Cholesterol and Statins in Alzheimer's Disease
Miller and Chacko
The Annals of Pharmacotherapy 2004;38:91-98.
ABSTRACT | FULL TEXT  

Validity and Reproducibility of a Food Frequency Questionnaire by Cognition in an Older Biracial Sample
Morris et al.
Am J Epidemiol 2003;158:1213-1217.
ABSTRACT | FULL TEXT  

Early Life Conditions and Cognitive Functioning in Later Life
Everson-Rose et al.
Am J Epidemiol 2003;158:1083-1089.
ABSTRACT | FULL TEXT  

A population-based longitudinal study of cognitive functioning in the menopausal transition
Meyer et al.
Neurology 2003;61:801-806.
ABSTRACT | FULL TEXT  

Cognitive activity and cognitive decline in a biracial community population
Wilson et al.
Neurology 2003;61:812-816.
ABSTRACT | FULL TEXT  

Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert et al.
Arch Neurol 2003;60:1119-1122.
ABSTRACT | FULL TEXT  

Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris et al.
Arch Neurol 2003;60:940-946.
ABSTRACT | FULL TEXT  

Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E
Nathoo et al.
Mol. Pathol. 2003;56:132-136.
ABSTRACT | FULL TEXT  

Apolipoprotein E, Alzheimer Disease, and African Americans
Mayeux
Arch Neurol 2003;60:161-163.
FULL TEXT